drugset / Trial / NCT01232023
Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Non-randomizedParallel-groupOpen-labelSupportive care
Summary
This study is designed to evaluate the pharmacokinetic and pharmacodynamic characteristics of indobufen in healthy subjects.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indobufen | Small molecule | 100 mg | Oral |
| Subject | Indobufen | Small molecule | 200 mg | Oral |
| Subject | Indobufen | Small molecule | 400 mg | Oral |
| Subject | Indobufen | Small molecule | 800 mg | Oral |
Indications
No indication recorded.